68Ga-ZHER2 PET/CT Reveals HER2-Positive Metastatic Gastric Cancer With Better Image Quality Than 18F-FDG. (February 2020)

• Record Type: Journal Article
• Authors: Zhou, Nina; Guo, Xiaoyi; Yang, Min; Zhu, Hua; Yang, Zhi
• Is Part Of: Clinical nuclear medicine. Volume 45:Number 2(2020)
• Publication Date: 2020-02
• Subjects: 68Ga-ZHER2 -- PET/CT -- 18F-FDG -- HER2 -- gastric cancer; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000002859
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: A 40-year-old woman with suspected recurrent HER2-positive gastric cancer underwent both 18 F-FDG PET/CT and 68 Ga-ZHER2 PET/CT. Both scans revealed multiple lesions in bones and the left supraclavicular lymph node. Compared with 18 F-FDG, 68 Ga-ZHER2 PET/CT showed better image contrast, especially in the bone lesions.